IRX Trademark

Trademark Overview

On Thursday, May 11, 2017, a trademark application was filed for IRX with the United States Patent and Trademark Office. The USPTO has given the IRX trademark a serial number of 87445502. The federal status of this trademark filing is REGISTERED as of Tuesday, June 26, 2018. This trademark is owned by AMD Labs, LLC. The IRX trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery systems for the delivery of ophthalmic pharmaceuticals and preparations, namely, devices for administering eye drops
irx

General Information

Serial Number87445502
Word MarkIRX
Filing DateThursday, May 11, 2017
Status700 - REGISTERED
Status DateTuesday, June 26, 2018
Registration Number5504470
Registration DateTuesday, June 26, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements

Goods and ServicesDrug delivery systems for the delivery of ophthalmic pharmaceuticals and preparations, namely, devices for administering eye drops

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, May 16, 2017
Primary Code010
First Use Anywhere DateSunday, April 1, 2018
First Use In Commerce DateSunday, April 1, 2018

Trademark Owner History

Party NameAMD Labs, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFort Myers, FL 33907
Party NameAMD Labs, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFort Myers, FL 33907
Party NameAMD Labs, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFort Myers, FL 33907

Trademark Events

Event DateEvent Description
Wednesday, July 5, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, June 26, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 26, 2018REGISTERED-PRINCIPAL REGISTER
Friday, May 25, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 24, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 24, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, May 24, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 24, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, May 24, 2018SU-EXAMINER'S AMENDMENT WRITTEN
Friday, May 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 3, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, April 16, 2018USE AMENDMENT FILED
Thursday, May 3, 2018SOU EXTENSION 1 GRANTED
Monday, April 16, 2018SOU EXTENSION 1 FILED
Thursday, May 3, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 16, 2018TEAS EXTENSION RECEIVED
Monday, April 16, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, November 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 10, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 15, 2017NEW APPLICATION ENTERED

Related Keywords

delivery devices administering drops namely pharmaceuticals systems ophthalmic drug preparations